MEDINCELL S.A. earnings
Annual earnings per share (EUR per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2026 | 2026-03-31 | €-0.94 | €-0.94 | 2026-08-04 16:42:09.152584 |
| 2025 | 2025-03-31 | €-0.62 | €-0.62 | 2026-08-04 16:42:09.152584 |
Revenue & profit (EUR)
| Concept | 2026 | 2025 |
|---|---|---|
| Revenue | €24.3M | €27.7M |
| Profit for the year | -€31.3M | -€18.4M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in MEDINCELL S.A.'s ESEF annual reports (source:
filings.xbrl.org).
Figures are in EUR, as reported. Not investment advice.